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Age-related declines in episodic memory performance are frequently reported, but their mechanisms remain poorly understood. 
Although several genetic variants and vascular risk factors have been linked to mnemonic performance in general and age differences 
therein, it is unknown whether and how they modify age-related memory declines. To address that question, we investigated the effect 
of Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism that affects secretion of BDNF, and fasting blood glucose level 
(a vascular risk factor) on episodic memory in a sample of healthy volunteers (age 19–77). We found that advanced age and high-normal 
blood glucose levels were associated with reduced recognition memory for name-face associations and poorer prose recall. However, 
elevated blood glucose predicted lower memory scores only in carriers of the BDNF 66Met allele. The effect on associative memory 
was stronger than on free recall. These ﬁ  ndings indicate that even low-level vascular risk can produce negative cognitive effects in 
genetically susceptible individuals. Alleviation of treatable vascular risks in such persons may have a positive effect on age-related 
cognitive declines.
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INTRODUCTION
Episodic memory declines with age (Verhaeghen et al., 1993) 
and associative memory tasks that require binding of multiple 
pieces of information may be especially sensitive to aging (Old 
and Naveh-Benjamin, 2008). However, biological underpinnings 
of age-related memory declines remain unclear. Multiple factors, 
including heredity (Finkel et al., 1995) and metabolic character-
istics (e.g., glycemic control; Rolandsson et al., 2008; Vanhanen 
et al., 1997; Yaffe et al., 2004) affect memory performance, but 
little is known about whether and how interactions among them 
contribute to age-related differences in memory.
Recent developments in genomic technology have advanced 
a more nuanced understanding of how speciﬁ  c genetic varia-
tions inﬂ  uence cognitive skills. Among single-nucleotide poly-
morphisms (SNPs) that affect cognitive performance, some 
have been linked speciﬁ  cally to episodic memory. One such SNP 
is a variant in a gene that controls secretion of the Brain-Derived 
Neurotrophic Factor (BDNF) in the central nervous system 
(CNS). BDNF plays an important role in cellular mechanisms 
of memory consolidation: calcium-dependent modiﬁ  cations of 
dendritic structure, synaptogenesis, and long-term potentiation 
(Finkbeiner, 2000; Lynch et al., 2006). The low-activity (Met) 
allele of a common BDNF polymorphism (Val66Met) is associ-
ated with reduced BDNF expression (Egan et al., 2003), and may 
confer disadvantage in performance on memory tasks (Bath and 
Lee, 2006). To date, six studies in non-pathological populations 
found that carriers of the BDNF Met66 allele have poorer ver-
bal memory than Val homozygotes (Dempster et al., 2005; Egan 
et  al., 2003; Goldberg et  al., 2008; Ho et  al., 2006; Miyajima 
et al., 2007; Raz et al., in press) and one study of younger adults 
found a similar Val/Val advantage in a scene recognition task 
(Hariri et al., 2003). In contrast, two studies revealed no asso-
ciation between BDNF Val66Met and memory (Hansell et al., 
2007; Harris et al., 2006). Thus the preponderance of evidence 
reported to date indicates that the BDNF 66Met allele may be a 
negative modiﬁ  er of memory.
Aging is associated with a reduction of BDNF expression 
during learning-related plasticity (Sohrabji and Lewis, 2006), 
and therefore factors that affect BDNF secretion may explain 
some of the age-related variability in memory. Little is known 
about the effect of BDNF on age differences in memory, as the 
vast majority of the extant studies have not employed samples 
covering a sufﬁ  ciently broad age range. Furthermore, most of the 
available studies of BDNF Val66Met and memory did not take 
into account physiological characteristics and   environmental 
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factors that may inﬂ  uence the expression of genes and thus 
affect cognitive performance. Physiological risk factors may 
interact with genetic risk to exert an adverse effect on cognitive 
performance. Indeed, we found that hypertension has a nega-
tive effect on speed of processing in carriers of the BDNF 66Met 
allele (Raz et al.,  in  press). Although we found a signiﬁ  cant 
negative effect of BDNF 66Met allele on memory in that study, 
no interactions with hypertension were observed. Nonetheless, 
it is possible that other indicators of vascular risk and vascular 
health more closely associated with BDNF activity are capable 
of affecting memory.
One group of factors that may act as age-dependent negative 
modiﬁ  ers of cognitive performance consists of variables asso-
ciated with glycemic control. High levels of blood glucose that 
contribute to cardiovascular morbidity (Coutinho et al., 1999) 
have a negative impact on memory in older adults, even at eleva-
tions short of a clinical diagnosis of diabetes (Riby et al., 2008; 
Rolandsson et al., 2008). Notably, BDNF and glucose are mutu-
ally dependent factors in multiple neural processes. BDNF facili-
tates glucose uptake in the brain (Mattson et al., 2004), increase 
in blood glucose levels inhibits brain release of BDNF (Krabbe 
et al., 2007), BDNF-deﬁ  cient knockout mice develop hypergly-
cemia (Lyons et al., 1999), and BDNF administration improves 
glucose metabolism in experimental diabetes (Nakagawa et al., 
2002). Thus, genetic reduction in BDNF release may affect cog-
nition in a speciﬁ  c biochemical environment, such as elevated 
glucose levels, and genetic and metabolic factors may synergisti-
cally inﬂ  uence memory. Moreover, such synergistic effects may 
be exacerbated by old age. Furthermore, in persons with genetic 
predisposition, lesser dose of a potential risk factor such as high-
normal blood glucose may be needed to produce the effect.
Therefore, in this study we examined the joint effects of BDNF 
Val66Met genotype and blood glucose on episodic memory in 
a healthy adult lifespan sample. We hypothesized that BDNF 
Val66 homozygotes would perform better than BDNF Met66 
carriers on an associative memory task, with lesser or no effect 
of the genotype expected on a task with no associative (binding) 
component. Furthermore, we hypothesized that higher blood 
glucose would be associated with poorer memory performance 
and the difference would be exacerbated by lower CNS levels 
of BDNF as expected for the low-activity allele of the Val66Met 
polymorphism. To test the hypothesis that higher, but clinically 
normal, blood glucose levels would be associated with reduced 
memory performance in genetically susceptible individuals, we 
selected a sample of normotensive and normoglycemic adults.
MATERIALS AND METHODS
PARTICIPANTS
The participants were recruited as a part of an ongoing longi-
tudinal study of healthy aging through local media. They were 
screened via health questionnaire and a telephone interview for 
history of cardiovascular, neurological and psychiatric condi-
tions, head trauma, alcohol and drug abuse, thyroid problems, 
and diabetes. The participants had corrected visual acuity 
of 50/20 or better (Optic 2000, Stereo Optic) and hearing of 
40 dB or better for frequencies of 500–4000 Hz (Maico, MA27). 
They were screened for dementia and depression with the 
Mini-Mental State Examination (MMSE; Folstein et al., 1975) 
and the Geriatric Depression Questionnaire (CES-D; Radloff, 
1977). Only persons who scored 26 or above on MMSE and 15 
or below on CES-D were invited to participate. All participants 
provided written informed consent in accord with the Wayne 
State University Human Investigation Committee.
The full complement of genetic, blood, and memory data 
were available for 103 volunteers (73 women, age range 19–77, 
mean ± SD: 53.24 ± 14.23), who were part of a larger sample 
of 189 participants (Raz et  al., in press). The participants 
were normotensive (systolic blood pressure 91–140  mm Hg, 
118.58 ± 10.90 mm Hg; diastolic blood pressure 60–89 mm Hg, 
73.50 ±  6.63  mm Hg), and normoglycemic (fasting blood 
 glucose  86.59  ± 9.32, 66–113 mg/dl). The education was 15.75 ± 
2.06 years. MMSE scores ranged from 26 to 30 (29.10 ± 0.92). Men 
and women did not differ in age (p = 0.67), MMSE (p = 0.26), or 
systolic blood pressure (p = 0.23). There was a trend for men to 
have slightly higher glucose levels (p = 0.10) and higher diastolic 
blood pressure (p = 0.07) than women. Men had less than a year 
more schooling than women (p < 0.05). Only 8% of the partici-
pants smoked (21–27% expected in the general population) and 
81% reported exercising regularly (31% expected in the general 
population) (American Heart Association, 2005). Thus, the par-
ticipants were apparently healthier and better educated than a 
typical sample from the general population.
MEASURES OF VASCULAR HEALTH INDICATORS
Following a 12-h overnight fast whole blood glucose levels were 
assessed by standard enzymatic glucose oxidase method, and 
persons with blood glucose levels below 126 mg/dl (<7.0 mmol/l) 
were retained. Blood pressure was measured from the left arm 
of seated participants by a mercury sphygmomanometer (BMS 
12-S25) with a standard cuff (Omron Professional) on three sep-
arate days before administration of the cognitive tasks. Persons 
with mean systolic pressure of 140 mm Hg or mean diastolic 
pressure of 90 mm Hg and above were excluded.
GENOMIC ANALYSIS
DNA was isolated from buccal cultures in mouthwash   samples 
using a Gentra Autopure LS under the standard buccal cell 
protocol. For quality control, 10% direct repeats and DNA 
sequencing for veriﬁ  cation were performed with control DNA 
and no-template controls. All 5′-nuclease assays were run on an 
Applied Biosystems 7900. Polymorphism for BDNF (rs6265) 
was interrogated using a Taqman SNP Genotyping assay. DNA 
sequencing reactions were carried out using the 0.5× protocol 
for ABI PRISM BigDye Terminator Cycle Sequencing Ready 
Reaction Kit (Applied Biosystems). The sequencing extension 
products were puriﬁ  ed utilizing Sephadex, and analyzed on an 
ABI PRISM 3700 DNA Analyzer using a 50 cm capillary array.
The distribution of the BDNF Val66Met alleles ﬁ  t  the 
Hardy-Weinberg equilibrium (χ2 = 0.13, ns), with 60% being 
Val homozygotes, 34% Val/Met heterozygotes, and 6% with the 
Met/Met genotype. Due to the rarity of Met/Met in Caucasians 
in this sample and in the general population (http://www.ncbi.
nlm.nih.gov/SNP/snp_ref.cgi?rs=6265, accessed July 26, 2008), 
the alleles were grouped as BDNF Met+ (n = 41) and BDNF 
Met− (i.e., Val/Val, n = 62). Met carriers and Val/Val homozy-
gotes did not differ in age: t(101) = 0.58, ns.
MEMORY MEASURES
Name-picture associative memory.
Memory for Names from the Woodcock-Johnson Psycho-
educational Battery – Revised (WJPB-R; Woodcock and Johnson, 
1989) measured associative memory. In the task,   participants www.frontiersin.org
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viewed 12 consecutive line drawings of novel   stimuli (cartoons 
of “space creatures”) and were told each creature’s “name”, a 
nonsense word. During study, participants viewed 12  plates 
depicting space creatures, one “new” creature and eight foils per 
plate. The task was to point to the creature named by the exam-
iner. After a 20-min delay, the creatures (target plus eight alter-
natives per plate) were displayed again and the participant was 
asked to point to the creature named by the experimenter. At 
the delayed administration, each plate was displayed three times 
for a total of 36 trials. The performance indices were the total 
number of correct matches for immediate and delayed recogni-
tion. The reliability of the immediate and delayed scores is 0.91 
(Woodcock and Mather, 1989).
Story recall
Recall of a prose passage was assessed by the Logical Memory 
(LM) subtest from the Wechsler Memory Scale-Revised 
(WMS-R; Wechsler, 1987). Participants heard two short stories 
of just a few lines each. Following each presentation they were 
asked to relay the story verbatim. After a 20-min delay, partici-
pants were again asked to repeat the stories as close to the origi-
nal wording as they remembered. If they were unable to do so, a 
simple reminder cue was provided for one or both stories. The 
split-half reliability of this task is estimated at 0.74 for immedi-
ate and 0.75 for delayed presentation (Wechsler, 1987).
STATISTICAL ANALYSES
The data for each test were analyzed in two separate General 
Linear models. Memory performance indices (number of cor-
rect associations or number of correct prose segments) were 
dependent variables. Study-test delay was a repeated measures 
factor. Age and blood glucose levels, centered at sample means, 
were continuous predictors; sex and BDNF genotype (Met car-
riers vs. Val homozygotes) were categorical predictors. Second 
order interactions among all predictors were included in the 
models, but deleted if found nonsigniﬁ  cant  (p > 0.10);  the 
reduced models were then evaluated. We tested no higher-order 
interactions because some categories created by crossing of fac-
tors contained too few cases.
RESULTS
The correlations among age, blood glucose levels, and episodic 
memory scores are presented in Table 1. Fasting blood glucose 
levels were moderately related to age, but not to BDNF geno-
type: t(101) = 0.33, ns.
MEMORY FOR NAME-PICTURE ASSOCIATIONS
Results of the general linear model analysis are summarized 
in Table 2. The main effects of age, blood glucose level, and 
study-test delay were signiﬁ  cant. Poorer memory for name-
  picture   associations was linked with older age, higher blood glu-
cose levels, and a delay between study and test. The effect of blood 
glucose on association memory was modiﬁ  ed by signiﬁ  cant 
interactions: BDNF  ×  Glucose and Delay  × BDNF × Glucose. 
The interactions reﬂ  ected the impact of the BDNF genotype 
on strength of association between glucose levels and memory. 
Signiﬁ  cant correlations between memory and blood glucose 
levels were observed only among the BDNF 66Met carriers: 
r = −0.50 for immediate and r = −0.49 for delayed recognition, 
both p < 0.001. As is shown in Figure 1, no association between 
blood glucose and immediate memory score was noted for Val 
homozygotes: r = 0.14, ns; a trend for delayed recognition was 
observed: r = −0.25, p < 0.06.
Although the main effect of age was statistically modiﬁ  ed by 
BDNF genotype and a delay between study and test, decomposi-
tion of that interaction revealed only small and probably trivial 
differences. Speciﬁ   cally, among Val homozygotes, age differ-
ences were stronger in immediate than delayed recall (r = −0.51, 
p < 0.001 vs. r = −0.42, p < 0.01), and in the opposite direction 
for the Met carriers: r = −0.44,  p <  0.001, for immediate vs. 
r = −0.50, p < 0.001 for delayed.
STORY RECALL
The main effect of age reﬂ  ected better performance by younger 
participants. The magnitude of age differences in story recall 
was smaller than in associative memory: Z* = 2.32, p < 0.05 for 
delayed, and Z* = 2.67, p < 0.01 for immediate recall. The rela-
tion between blood glucose levels and delayed story recall was 
also weaker than for delayed associative memory: Z* = 2.03, 
p < 0.05. The difference for immediate memory was not signiﬁ  -
cant, albeit in the same direction: Z* = 1.16, ns. The modifying 
inﬂ  uence of BDNF Val66Met can be seen in Figure 2. Among 
BDNF Met carriers, higher glucose levels were associated with 
lower LM scores: r = −.36, p < 0.05 for delayed recall and a trend 
r = −.27, p < 0.09 for immediate recall. For BDNF Val homozy-
gotes, no such associations were observed: r = −.06 for immedi-
ate and r = 0.00 for delayed scores.
Table 1 | Memory, age, and fasting blood glucose: zero-order correlations.
 Age  Glucose  LM  LMd  NP
Blood glucose  0.36‡
Logical Memory  −0.20  −0.13
Logical Memory, delayed  −0.22*  −0.13 0.89‡
Name-picture  −0.48‡  −0.25* 0.35‡ 0.39‡
Name-picture, delayed  −0.44‡  −0.33† 0.44‡ 0.47‡ 0.87‡
*p < 0.05, †p < 0.01, ‡p < 0.001.
LM, Logical Memory; LMd, Logical Memory, delayed recall; NP, name-picture.
Table 2 | Effects of age, fasting blood glucose, and BDNF Val66Met poly-
morphism on episodic memory.
  Name-picture associations recognition
Effect  F (1,96)  p
Age 20.79  0.001
Glucose 4.71  0.032
Sex 0.52  0.472
BDNF 1.43  0.235
BDNF × glucose  6.47  0.013
Delay 2546.34  0.001
Delay × BDNF × age  4.14  0.045
Delay × BDNF × glucose   4.25  0.042
Story recall
Age 4.60  0.035
Delay 81.85  0.001
Delay × sex × glucose  2.79  0.098
Delay × glucose × BDNF  3.95  0.050
Nonsigniﬁ  cant main effects (F < 1) were included in the models but are not shown; 
nonsigniﬁ  cant interactions (p > 0.10) were removed from the models.
BDNF, Brain-derived neurotrophic factor; delay, immediate test versus test 20-min after 
study.Frontiers in Human Neuroscience  | October  2008 | Volume  2 | Article  12
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DISCUSSION
As hypothesized, we found that in addition to age, high-normal 
fasting blood glucose has a negative impact on episodic memory, 
but this relationship was limited to carriers of the low-activity 
BDNF allele. Moreover, the synergistic effect of BDNF Met and 
blood glucose on memory was more pronounced in associative 
memory than prose recall. Whereas the age differences in mem-
ory and the link between memory and a vascular health indica-
tor replicate results reported in the literature, modiﬁ  cation of the 
glucose effect on memory by a genetic factor is a novel ﬁ  nding. 
Unlike our previous ﬁ  ndings of BDNF Met effect on memory in 
a sample that contained persons with hypertension (Raz et al., 
in press), the reported synergistic effect was observed in healthy 
participants. Although truncation of glucose range probably 
  produced a smaller effect than could have been observed in the 
full range of that variable, it is important to underscore that our 
ﬁ  ndings were observed in a sample of persons unaffected by mul-
tiple health complications associated with clinically diagnosed 
diabetes mellitus.
Blood glucose level is a metabolic index statistically distrib-
uted within a rather wide range. Elevation of blood levels of glu-
cose above an established cut-off, in conjunction with clinical 
symptoms, entails a diagnosis of diabetes. However, high nor-
mal blood glucose levels below the currently accepted cutoff 
for diabetes may represent early, preclinical diabetes. It is pos-
sible that individual cut-off values for a “normal” glucose level 
should be adjusted upwards or downwards depending on the 
genetic factors that affect glucose metabolism. Although larger-
scale studies are needed to assess the need for such adjustment, 
our results suggest that levels of glucose at the upper end of the 
clinically normal range may be associated with negative effects 
on memory in genetically predisposed individuals. A possibility 
Figure 1 | Name-picture association recognition and blood glucose modiﬁ  ed by BDNF Val66Met genotype. BDNF Val66Met Met carriers (red triangles, 
broken regression line) are compared to BDNF Val homozygotes (black circles, solid regression line). (A) Immediate recognition. (B) Delayed recognition.
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that differential survival of Val homozygotes biased the ﬁ  ndings 
was not a threat to validity in this sample as there were no age 
differences between the genotype groups.
One of the implications of our ﬁ  ndings is that in compari-
son to carriers of the BDNF 66Met allele, Val homozygotes may 
be able to afford higher levels of glucose without detriment to 
their memory performance. The mechanisms underpinning the 
observed synergistic effect remain to be elucidated. Although 
increase in glucose levels inhibits BDNF release in the brain 
(Krabbe et  al., 2007), it is unknown if chronic reduction in 
BDNF elevates glucose levels. In this sample, BDNF Met carriers 
did not have higher glucose levels than Val homozygotes. Thus, 
it is unlikely that genetically reduced BDNF resulted in higher 
blood glucose levels, and that elevations in glucose levels per se 
are responsible for memory deﬁ  cits. The observed association is 
rather a marker of vulnerability in a genetically distinct group.
Glucose is not necessarily detrimental to memory perform-
ance. Moreover, acute glucose administration improves memory, 
especially in older adults (Gold, 2005; Messier, 2004), although 
the speciﬁ  city of that effect has been challenged (Kaplan et al., 
2000, 2001). Furthermore, memory performance may be nega-
tively affected by glycemic dysregulation even at normal fasting 
glucose levels (Awad et al., 2002). Therefore, blood glucose level 
may be important for memory function inasmuch as it reﬂ  ects 
other cellular and systemic processes. In healthy adults, elevated 
fasting glucose levels may reﬂ  ect reduced insulin availability 
or insulin insensitivity, which suppresses memory scores in an 
age-dependent manner (Craft, 2005). Thus, additional research 
employing glucose regulation measures (i.e., insulin levels) may 
clarify the nature of BDNF modiﬁ  cation of the link between 
memory and glucose metabolism. Because insulin levels were 
not assessed in the current study, this question remains open. 
It is also possible that increases in peripheral glucose levels do 
not imply its elevation in the brain. Brain and peripheral glu-
cose levels are not controlled by the same mechanisms (Béquet 
et al.,  2000) and chronic excess of extracellular glucose may 
be related to its reduced availability for intracellular processes, 
especially in the brain. Thus, our ﬁ  ndings do not contradict the 
literature that links acute increases in blood glucose to improved 
memory. However, the effect of BDNF on such interventions is 
unknown.
The ﬁ  ndings should be viewed in light of this study’s limita-
tions. First, although the BDNF-glucose interaction suggests a 
gene-environment interaction and possibly an epigenetic effect, 
it may in part be due to an interaction among multiple genes. It 
is unclear how much of the observed variance in fasting blood 
glucose is due to environment vs. genes. Investigations reported 
after completion of this study found that fasting blood glucose 
levels may be controlled by variants of the G6PC2 (Bouatia-
Naji et al., 2008) and ENPP1 (Stolerman et al., 2008) genes. The 
inﬂ  uence of those genes on memory functions sensitive to glu-
cose levels merits future inquiry.
Second, although two memory indices were used in this study, 
not all components of episodic memory processes (e.g., encod-
ing, consolidation, and retrieval) were assessed. These processes 
must be examined in greater detail to clarify the cognitive locus 
of the observed effect. A study focusing on the costs of associa-
tive binding is needed in order to establish whether speciﬁ  cally 
the associative component of memory is indeed more vulner-
able to BDNF-glucose inﬂ  uence than other operations.
Third, one test measured recognition, whereas the other meas-
ured free recall. Because free recall is generally more   sensitive to 
age effects and considered to be more difﬁ  cult than recognition 
(Craik and McDowd, 1987), the results may reﬂ  ect task difﬁ  -
culty. However, because the bias would be in the opposite direc-
tion than was found in this study, we have more conﬁ  dence that 
the ﬁ  ndings reﬂ  ect the difference in memory modes. A tempting 
interpretation that greater effects of BDNF and blood   glucose 
on associative memory indicate a BDNF role in a speciﬁ  c bind-
ing deﬁ  cit should be viewed with caution. The prose paragraph 
recall task, though widely used in previous studies with mixed 
results (Dempster et al., 2005; Egan et al., 2003; Harris et al., 
2006), is less reliable than the name-picture association task 
employed in this study. Thus, the difference in effect size may 
reﬂ  ect differential reliability of the tests. Future investigations 
are needed to disentangle various cognitive mechanisms that 
may underlie the observed gene-vascular risk interaction on 
episodic memory.
Fourth, although the study sample afforded sufﬁ  cient power 
to discover the interactive effects reported here, it was not suf-
ﬁ  ciently large to allow examination of higher-order interactions 
with other genes and other vascular risk factors. To establish if 
such interactions are possible, a much larger sample is needed.
Fifth, the cross-sectional design of the study does not permit 
assessment of true change, variability of change, or the estab-
lishment of causal links between glucose levels and cognitive 
performance. It is possible that high-normal glucose values 
observed in this sample are indicators of a pathological proc-
ess that may produce higher and clinically signiﬁ  cant values in 
a span of several years. Thus, the observed relationship may be 
a harbinger of an incipient metabolic disease. We hope that the 
longitudinal follow-up on participants of this study will shed 
light on the associations between age-related change in memory, 
genetic predisposition, and glycemic control.
In sum, we have demonstrated that genetic predisposition for 
reduced production of BDNF is associated with increased vul-
nerability to the negative effects of high-normal blood glucose 
levels in healthy adults without known vascular or metabolic 
disease. This synergistic effect may be more pronounced for 
memory tasks that require binding information and formation 
of associations. The results of this study suggest that interac-
tions of speciﬁ  c genetic vulnerability and treatable vascular risks 
should be taken into account in conducting memory assessment 
and designing memory rehabilitation interventions for older 
adults.
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